載入...
Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
Thousands of cancer patients are currently in clinical trials evaluating antiangiogenic therapy in the neoadjuvant setting, which is the treatment of localized primary tumors prior to surgical intervention. The rationale is that shrinking a tumor will improve surgical outcomes and minimize growth of...
Na minha lista:
發表在: | EMBO Mol Med |
---|---|
Main Authors: | , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BlackWell Publishing Ltd
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4287975/ https://ncbi.nlm.nih.gov/pubmed/25361689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201403989 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|